Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

FDA Approves Generic Formulations of Lamivudine and Zidovudine Tablets and Nevirapine Tablets and Oral Suspension

May 25, 2012

The FDA recently approved generic formulations for the following antiretroviral agents:

  • Lamivudine and zidovudine tablets, 150 mg/300 mg (see the FDA press release)
  • Nevirapine tablets, 200 mg, and oral suspension, 50 mg/mL

FDA approval of the generic formulations means that they may be marketed in the United States.

A comprehensive list of the approved generic HIV therapeutic drug products is available on the FDA HIV website.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.
 
See Also
More on the FDA Drug Approval Process and Other Regulatory Issues

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement